Search

Issue
Title
Authors
The attitude of patients with types 1 and 2 diabetes mellitus towards having the disease
Sapozhnikova I.E., Zotina E.N.
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Karaseva E.A., Martynov V.A., Filatova T.E., Maleev V.V., Grishin V.Y., Pronin N.S., Verbitskaya E.I., Popova V.I.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E.L., Vaizova O.E., Meleshko M.V., Samoilova I.G., Podchinenova D.V., Borozinets A.A., Matveeva M.V., Kudlay D.A.
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O.V., Evdokimova N.E., Timoshchenko O.V., Latyntseva L.D.
Long-term uroseptic and metabolic effects of a herbal medicinal preparation in women with type 2 diabetes taken gliflosins
Tsygankova O.V., Timoshchenko O.V., Apartseva N.E., Latyntseva L.D.
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Sturov N.V., Popov S.V., Mamporia N.K., Mager A.A.
The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk
Mustafina S.V., Ovsyannikova A.K., Voevoda M.I., Denisova D.V., Sherbakova L.V., Rymar O.D.
Hypoglycemia in patients with type 2 diabetes mellitus: Safe solution of the dangerous problem
Shestakova M.V., Khalimov I.S.
Obesity without diabetes: the role of hormonal regulation
Shestakova E.A., Sklyanik I.A., Panevina A.S., Nikankina L.V., Shestakova M.V., Dedov I.I.
Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
Dedov I.I., Melnichenko G.A., Troshina E.A., Ershova E.V., Mazurina N.V., Ogneva N.A., Yashkov Y.I., Ilyin А.V.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I.I., Severina A.S., Shamkhalova M.S., Shestakova M.V.
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
Samoilova I.G., Vaizova O.E., Stankova A.E., Matveeva M.V., Podchinenova D.V., Kudlay D.A., Borozinets A.A., Filippova T.A., Grishkevich I.R., Partala A.V., Gerasimova D.A.
Leptin and leptin receptor evaluation in atherosclerotic plaques in patients with type 2 diabetes mellitus
Dimitrova D.A., Mikhailov I.A., Tokarev K.Y., Michurova M.S., Gorbacheva A.M., Danilova N.V., Malkov P.G., Kalashnikov V.Y.
The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus
Chernikova N.A., Kamynina L.L., Ametov A.S., Sychev D.A., Grishina E.A., Ryzhikova K.A.
A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition
Shestakova M.V., Sukhareva O.I., Chernova T.O., Shmushkovich I.A., Aleksandrov A.A., Il'in A.V., Dedov I.I.
Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
Teplyakov A.T., Torim Y.Y., Kuznetsova A.V., Rybal'chenko E.V., Krylov A.L., Karpov R.S., Teplyakov A.T., Torim Y.Y., Kuznetsova A.V., Rybalchenko E.V., Krylov A.L., Karpov R.S.
Ala54Thr polymorphism of the fatty acid transporter gene (FABP2) in patients with type 2 diabetes mellitus in Yakutia
Sydykova L.A., Pavlova N.I., Bochurov A.A., Alekseev V.A., Krylov A.V., Kurtanov K.A., Shestakova M.V.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V.V., Shamkhalova M.S., Duganova A.V.
SGLT2 inhibitors in acute decompensated heart failure, what do we know?
Lapteva A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes
Verner V.A., Mel’nik M.V., Knjazeva S.A.
Association of polymorphisms of genes TCF7L2, FABP2, KCNQ1, ADIPOQ with the prognosis of the development of type 2 diabetes mellitus
Mel’nikova E.S., Rymar O.D., Ivanova A.A., Mustafina S.V., Shapkina M.J., Bobak M., Maljutina S.K., Voevoda M.I., Maksimov V.N.
The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD)
Panevina A.S., Smetneva N.S., Vasilenko A.M., Shestakova M.V.
Chronic constipation in the practice of a therapist: Features of therapy for comorbidity
Svistunov A.A., Osadchuk M.A., Butorova L.I., Tokmulina G.M.
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V.I., Klimontov V.V., Myakina N.E., Tyan N.V., Fazullina O.N., Romanov V.V.
Thyroid dysfunction in patients with type 2 diabetes mellitus
Tereshchenko I.V., Suslina A.A.
Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus
Goncharenko O.N., Ametov A.S., Isakova M.R.
Acute coronary syndrome in patients with type 2 diabetes mellitus
Ametov A.S., P'yanykh O.P., Aslandziya E.N., Ametov A.S., Pianykh O.P., Aslandzia E.N.
Impact of insulin therapy on insulin resistance and a risk for coronary heart disease and cardiovascular death in patients with type 2 diabetes
Ametov A.S., Kochergina I.I., Ulanova K.A., Ametov A.S., Kochergina I.I., Ulanova K.A.
Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity
Kazymov M.S., Fishman B.B., Veber V.R., Fishman M.B., Kopina M.N., Kuprin P.E., Kazymov M.S., Fishman B.B., Veber V.R., Fishman M.B., Kopina M.N., Kuprin P.E.
Polymorphic variants of glutathione reductase – new genetic markers of predisposition to type 2 diabetes mellitus
Azarova I.E., Klyosova E.Y., Polonikov A.V.
Nephrolithiasis against type 2 diabetes mellitus: on the effect of hypoglycemic therapy on lithogenesis
Yarovoy S.K., Kareva E.N., Djalilov O.V.
The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives
Ametov A.S.
Carbohydrate metabolic disturbances and obstructive sleep apnea syndrome
Oleĭnikov V.É., Sergatskaia N.V.
The incidence of postoperative myocardial infarction and the left ventricular function in patients with type 2 diabetes mellitus after recanalization of chronic coronary occlusions
Petrenko I.V., Petrenko O.A., Popova M.A., Mamedova S.I., Urvantseva I.A.
Innovations in the treatment of type 2 diabetes mellitus: use of incretins
Dedov I.I., Shestakova M.V., Sukhareva O.Y., Dedov I.I., Shestakova M.V., Sukhareva O.Y.
Diabetes mellitus type 2: National Russian guidelines vs real clinical practice
Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Dedov I.I., Mokrysheva N.G.
Angiogenesis system, as a part of endothelial dysfunction in patients with diabetes mellitus type 2: relationship with obesity
Severina A.S., Shestakova M.V.
Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus
Kondrat'ev A.I., Dolgikh V.T., Stotskiy A.O., Kondratyev A.I., Dolgikh V.T., Stotsky A.O.
Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms
Isakova Z.T., Talaibekova E.T., Asambaeva D.A., Kerimkulova A.S., Lunegova O.S., Aldasheva N.M., Aldashev A.A.
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
Bakulin I.G., Sandler Y.G., Vinnitskayа E.V., Keiyan V.A., Rodionova S.V., Rotin D.L.
Leptin, resistin, and hormonal and metabolic parameters in women with type 2 diabetes and in those with its concurrence with asthma
Verbovoy A.F., Kosareva O.V., Akhmerova R.I.
Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention
Shishkova V.N.
Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy
Statsenko M.E., Derevianchenko M.V.
The degree of alexithymia in type 2 diabetes mellitus patients and its association with medical and demographic parameters
Sapozhnikova I.E., Tarlovskaia E.I., Madianov I.V., Vedenskaia T.P.
Taurin in combined treatment of metabolic syndrome and diabetes mellitus
Ametov A.S., Kochergina I.I., Doskina E.V., Abaeva B.S., Elizarova E.P., Ametov A.S., Kochergina I.I., Doskina E.V., Abaeva B.S., Elizarova E.P.
Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes
Shvarts V., Schwarz V.
Comparative analysis of the drugs efficacy for carbohydrate metabolism early disorders (prediabetes) treatment: A review
Mkrtumyan A.M.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O.M., Martynov A.I., Arutyunov G.P., Bakulin I.G., Livzan M.A., Maev I.V., Egorov I.V.
Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes
Lankin V.Z., Tikhaze A.K., Konovalova G.G., Odinokova O.A., Doroshchuk N.A., Chazova I.E.
Glycemic variability and oxidative stress in patients with type 2 diabetes mellitus during combined glucose-lowering therapy
Butaeva S.G., Ametov A.S., Bugrov A.V., Dolgov V.V.
The concurrence of diabetes mellitus and gallstone disease
Tereshchenko I.V., Kamenskikh Y.A., Kayushev P.E.
The state of the great arteries in type 2 diabetes mellitus patients with obstructive sleep apnea syndrome
Oleynikov V.E., Sergatskaya N.V., Gusakovskaya L.I., Khromova A.A.
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A.S., Gusenbekova D.G.
Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
Oskola E.V., Shubina A.T., Karpov I.A.
Osteoarthrosis in patients with type 2 diabetes mellitus
Asfandiiarova N.S., Nizov A.A., Nekhaeva T.I., Sakaeva N.A., Filatova T.E., Zhuravleva N.S., Trunina T.P.
СРАР therapy for obstructive sleep apnea syndrome in patients with carbohydrate metabolic disturbances and type 2 diabetes mellitus
Oleĭnikov V.É., Sergatskaia N.V.
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism
Lavrenko A.V., Shlykova O.A., Kutsenko L.A., Mamontova T.V., Kaĭdashev I.P.
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A.S., Kamynina L.L., Ametov A.S., Kamynina L.L.
Correlation of HbA1c and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes receiving glibenclamide
Dreval A.V., Cheporeva O.N., Redkin Y.A., Misnikova I.V.
Effects of combined treatment with rosiglitazone and NPH insulin on carbohydrate metabolism in patients with type 2 diabetes mellitus
Kandalintseva O.A., Ametov A.S., Kandalintseva O.A., Ametov A.S.
Method for predicting the risk of type 2 diabetes mellitus development in persons with visceral obesity and prediabetes
Nelaeva Y.V., Nelaeva A.A., Yuzhakova A.E., Petrov I.M., Sholomov I.F.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N.A., Telnova M.E., Goncharova E.V., Martirosian N.S., Kuzina I.A.
Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus
Samoilova I.G., Matveeva M.V., Kudlay D.A., Tonkikh O.S., Tolmachev I.V.
Gene therapy of type 2 diabetes mellitus: state of art
Stafeev Y.S., Menshikov M.Y., Parfyonova Y.V.
Immunogenic lipid markers of atherosclerosis in type 2 diabetic patients on program haemodialysis
Archakova T.V., Nedosugova L.V., Nikitina N.A., Melnichenko A.A., Sobenin I.A.
Microcirculatory parameters in compensated and decompensated type 2 diabetes mellitus
Suchkova O.V., Gurfinkel Y.I., Sasonko M.L.
Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
Ametov A.S., Kamynina L.L., Akhmedova Z.G.
Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus
Statsenko M.E., Derevianchenko M.V., Titarenko M.N., Mikhaleva A.V.
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
Ametov A.S., Kamynina L.L.
A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus
Biriukova E.V.
Cytokine gene polymorphism in type 2 diabetes mellitus in the Europeoid women of Russia
Konenkov V.I., Korolev M.A., Shevchenko A.V., Lapsina S.A., Koroleva E.A., Zonova E.V., Prokof'ev V.F.
Capabilities of sugar-lowering therapy in women with decompensated type 2 diabetes mellitus
Onuchin S.G., Elsukova O.S., Solovyev O.V., Onuchina E.L.
Current approaches to controlling type 2 diabetes
Ametov A.S., Karpova E.V., Ivanova E.V., Ametov A.S., Karpova E.V., Ivanova E.V.
Comparison of effects of carbohydrate metabolism compensation and atorvastatin treatment on lipid metabolism and C-reactive protein in type 2 diabetes mellitus
Glinkina I.V., Zilov A.V., Mel'nichenko G.A., Roytman A.P., Il'in A.V., Glinkina I.V., Zilov A.V., Melnichenko G.A., Roitman A.P., Ilyin A.V.
The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study
Sasunova A.N., Goncharov A.А., Gapparova K.M., Isakov V.A.
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M.A., Vorobyev S.V., Butova H.N.
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)
Oschepkova E.V., Aksenova A.V., Orlovsky A.А., Chazova I.E.
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
Sklyanik I.A., Shestakova M.V.
Gut microbiota is a factor of risk for obesity and type 2 diabetes
Demidova T.Y., Lobanova K.G., Oinotkinova O.S.
Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
Verbovoy A.F., Pashentseva A.V., Verbovaya N.I., Madyanov I.V., Sharonova L.A., Galkin R.A.
Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and coronary artery disease: Diagnosis and severity assessment
Beshlieva D.D., Kalashnikov V.Y., Smirnova O.M.
Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm Region after 10 years
Tereshchenko I.V., Suslina A.A.
Relationships between serum lipid composition and acetylator status as markers of energy metabolism in women with coronary heart disease, metabolic syndrome, and type 2 diabetes mellitus
Matveeva S.A.
Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS
Eliseev M.S., Barskova V.G., Eliseev M.S., Barskova V.G.
Influence of chronic cardiac failure severity on the course of comorbid type 2 diabetes mellitus
Narusov O.Y., Lapina Y.V., Mareev V.Y., Bolotina M.G., Shestakova M.V., Masenko V.P., Baklanova N.A., Belenkov Y.N., Narusov O.Y., Lapina Y.V., Mareev V.Y., Bolotina M.G., Shestakova M.V., Masenko V.P., Baklanova N.A., Belenkov Y.V.
Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review
Demidova T.Y., Titova V.V., Izmaylova M.Y.
Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate
Soboleva G.N., Minasyan A.A., Gaman S.A., Rogoza A.N., Molina L.P., Soboleva T.V., Shariya M.A., Ternovoy S.K., Karpov Y.A.
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
Demidova T.Y., Lobanova K.G., Perekhodov S.N., Antsiferov M.B., Oynotkinova O.S.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A.V., Sandler Y.G., Khaimenova T.Y., Keyan V.A., Saliev K.G., Sbikina E.S., Vinnitskaya E.V.
Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
Shestakova E.A., Il'in A.V., Shestakova M.V., Dedov I.I.
Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
Statsenko M.E., Derevianchenko M.V., Ostrovskiĭ O.V., Titarenko M.N., Shvets M.K., Bondarev A.M.
Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2
Osipenko M.F., Zhuk E.A., Medvedeva O.V.
Diabetes mellitus is an independent risk factor for cardiovascular disease
Ametov A.S., Kulidzhanian N.K.
Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
Ametov A.S., Pyanykh O.P., Chernikova N.A.
1 - 94 of 94 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».